This update addresses three important changes to pharmaceutical patents in the People’s Republic of China (PRC) in view of the newly amended PRC Patent Law (the Law), which will take effect on June 1, 2021, and the recent...more
In recent years, with the increase in patent applications filed in China, the China National Intellectual Property Administration (CNIPA) has focused on expediting patent examinations to decrease the duration of the normal...more
10/23/2019
/ China ,
CNIPA ,
Corporate Counsel ,
Intellectual Property Protection ,
Patent Applications ,
Patent Examinations ,
Patent Litigation ,
Patent Prosecution ,
Patent Prosecution Highway ,
Patents ,
Popular
Parties challenging patents under the post-issuance review proceedings authorized by the America Invents Act have long worried about estoppel in later district court cases if they lose before the Patent Trial and Appeal Board...more